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Abstract 
 
Background: To assess the role of ascorbic acid in 
portal triaditis caused by Rifampicin. 
Methods: In this experimental study, thirty adult 
BALB/c mice weighing 35-50 grams were taken. They were 
kept under standard laboratory conditions of temperature 
and humidity and light/dark cycle. Animals were given 
diet pellets.  Mice were randomized and  divided into 
three groups (n=10 animals in each group).Group A was 
given rifampicin in a dose of 100 mg/kg, Group B was 
given rifampicin 100 mg/kg along with Ascorbic acid 500 
mg/kg orally for 6 weeks.Group C was the control group  
Results: Histological examination of animals revealed 
significant change in portal triaditis in experimental group 
having Ascorbic Acid along with Rifampicin. 
Conclusion: Ascorbic acid has a protective role against 
Portal Inflammation caused by Rifampicin 
Key Words: Ascorbic Acid; Portal Inflammation; 
Rifampicin   
Introduction 
 
     Tuberculosis is one of the major causes of morbidity 
and mortality among infectious diseases world 
wide.About one third of world’s population has latent 
tuberculosis. According to a report published by 
World Health Organization Pakistan ranks 8th in 
terms of estimated number of cases with an incidence 
of 175/100,000 persons per year and a prevalence 
exceeding 1% of the total population.1-4 
     Isoniazid and rifampicin are the first line drugs for 
the treatment of tuberculosis. Damage to the liver 
caused by these drugs is  a serious challenge in the 
course of treatment and creates difficulties in 
restarting the regimen. Toxic metabolites may play an 
important role in the development of drug induced 
hepatotoxicity due to antituberculous drugs. 
Rifampicin is a potent inducer of several cytochrome 
P450 isoenzymes  leading to oxidative stress and  
production of reactive oxygen species (ROS) resulting 
in  hepatotoxic injury. Rifampicin can cause 
hepatocellular injury resulting in portal triaditis.5-9 
     There is an increasing interest in the idea that 
certain diseases are associated with reactive oxygen 
species (e.g., oxygen free radicals, hydrogen peroxide). 
Cells have a number of mechanisms for dealing with 
the toxic effects of oxygen. Recent studies indicate the 
existence of a strong correlation between hepatic 
injury and oxidant stress in experimental animals 
treated with anti-tuberculous drugs. Studies have been 
performed to prevent or reduce the toxicity by the use 
of natural herbal drugs or synthetic compounds, 
without interfering with the therapeutic actions of the 
drugs. Garlic, Silymarin, N-acetylcysteine and several 
other herbal drugs are proved to have such effects.10,11 
     Ascorbic acid (AA) is a potent water soluble 
antioxidant.It has the capability of protecting cells 
from oxidative stress and exhibits anti-inflammatory 
properties by preventing increased production of 
cytokines. Studies have been performed which 
showed that vitamin C has protective effect on cell 
apoptosis.  Treatment with ascorbic acid also arrests 
the activities of super oxide dismutase and glutathione 
peroxidase and inhibits  the radiation-induced lipid 
peroxidation in the skin of mice exposed to different 
doses of fractionated gamma radiation.12,13 
 
Materials and Methods 
     The study was carried out in the department of 
Anatomy, Army Medical College, Rawalpindi, in 
collaboration with National Institute of Health (NIH), 
Islamabad. Thirty adult male BALB/c mice having 
weight of 35-50 g and age between 10 -12 weeks were 
obtained from NIH, Islamabad.The mice were kept in 
animal house under standard laboratory conditions in 
NIH. Animals were randomly divided into 3 groups 
each containing 10 mice. All mice were acclimatized 
for one week. These mice were maintained on pelleted 
diet prepared at animal house. They were kept at 12 
hours light and dark cycle in a room at 22-24 0 C and 
were given food and water ad libitum.  
     Liver of the mice  were put in 10% formalin in 
plastic containers for 48 hours.  Filtered paraffin with 
melting point 56-580C was used for embedding. Slides 
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were prepared from right lobe of liver.  Light 
microscopic examination was done after staining of 
slides with H&E. For portal inflammation slides were 
examined under 10X objective. It was graded as 0 if no 
portal tract showed inflammatory cells and 1 even if 
one portal tract was seen infiltrated by inflammatory 
cells. 
     The control group received regular laboratory diet 
for 6 consecutive weeks. The mice in the  experimental 
group A were administered rifampicin orally in a dose 
of 100 mg/kg of body weight for 6 consecutive weeks. 
The mice in the experimental group B were 
administered rifampicin orally in a dose of 100 mg/kg 
of body weight with concurrent administration of 
ascorbic acid(analytical grde) in a dose of 500 mg/kg 
body weight for 6 consecutive weeks. 
 
Results 
     Histological analysis of slides stained with H&E of 
control group C did not reveal portal inflammation in 
any member of group. Observation of experimental 
group A showed portal inflammation in 90% of 
animals (Fig 1) while in experimental group B only 
50% of animals had portal inflammation while 50% of 
animals were normal ( Fig 2). The findings were 
statistically significant when compared by applying 
Chi square test (Table 1). 
 
Table-1:Comparison of Portal Inflammation  
Groups Absent (Grade 0) 
Present 
(Grade 1) p Value  
Control Group 
C (n=10) 100%  
0.00* 
Experimental 
Group A 10% 90% 
Experimental 
Group B 50% 50% 
Statistical difference by applying Chi square in grading of Portal 
Inflammation between: 
Group A and B  < 0.05*  
Group A and C  < 0.05* 
Group B and C  < 0.05* 
 
Discussion 
         All cells of the body are exposed to oxidative 
stress. The oxidants causing stress come from 
exogenous and endogenous sources as a consequence 
of different metabolic processes. To combat these 
prooxidants, antioxidant defence system plays an 
important role. Fat and water soluble vitamins like 
alpha tocopherol, beta carotene and ascorbic acid 
contribute in providing antioxidant defence system of 
the body. 14  
 
Fig 1: Section of liver of experimental group A showing 
portal triaditis  
 
 
Fig 2:Section of liver of experimental group B showing 
normal portal tract  
      
     Rifampicin is a  part of antituberculous regime and 
is potentially hepatotoxic drug. It is metabolised and 
detoxified in liver making this organ susceptible to 
injury. Drug-induced hepatic injury is a major health 
problem and accounts for more than 50% of cases of 
acute liver failure.15 
     The idiosyncratic nature and poor prognosis of 
drug induced liver injury make this type of reaction a 
major safety issue during drug development. Mice, a 
commonly used species in medical research, were 
preferred due to their short gestation period and easy 
maintenance. Researchers have successfully used mice 
as a hepatotoxic model.16,17 
To assess the protective role of antioxidants 
ascorbic acid was selected as it is easily available and 
has already received regulatory approval for 
treatment.18 There was remarkable portal 
inflammation in hepatic tissue of specimens obtained 
from group B animals. Presence of portal triaditis 
supports previous work which suggested that 
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abundance of inflammatory cells are hall mark of 
hepatic tissue facing injurious impacts.19,20 
Supplementation with ascorbic acid reduced 
inflammation as it is a potent antioxidant and reduces 
oxidative stress.21 
 
Conclusion 
Ascorbic acid reduced the incidence of portal 
inflammation but did not offer complete protection as 
50% of animals still had portal inflammation. 
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